ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15D9529
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Contrast Agents for Magnetic Resonance Imaging MRI Market Insights and Forecast to 2028
BUY CHAPTERS

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Research Report 2025

Code: QYRE-Auto-15D9529
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size

The global market for Contrast Agents for Magnetic Resonance Imaging (MRI) was valued at US$ 1527 million in the year 2024 and is projected to reach a revised size of US$ 2125 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Contrast Agents for Magnetic Resonance Imaging (MRI) Market

Contrast Agents for Magnetic Resonance Imaging (MRI) Market

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contrast Agents for Magnetic Resonance Imaging (MRI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contrast Agents for Magnetic Resonance Imaging (MRI).
The Contrast Agents for Magnetic Resonance Imaging (MRI) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contrast Agents for Magnetic Resonance Imaging (MRI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Contrast Agents for Magnetic Resonance Imaging (MRI) Market Report

Report Metric Details
Report Name Contrast Agents for Magnetic Resonance Imaging (MRI) Market
Accounted market size in year US$ 1527 million
Forecasted market size in 2031 US$ 2125 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Contrast Agents for Magnetic Resonance Imaging (MRI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Contrast Agents for Magnetic Resonance Imaging (MRI) Market growing?

Ans: The Contrast Agents for Magnetic Resonance Imaging (MRI) Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Contrast Agents for Magnetic Resonance Imaging (MRI) Market size in 2031?

Ans: The Contrast Agents for Magnetic Resonance Imaging (MRI) Market size in 2031 will be US$ 2125 million.

What is the market share of major companies in Contrast Agents for Magnetic Resonance Imaging (MRI) Market?

Ans: The top 3 companies hold a share about 82%.

Who are the main players in the Contrast Agents for Magnetic Resonance Imaging (MRI) Market report?

Ans: The main players in the Contrast Agents for Magnetic Resonance Imaging (MRI) Market are GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India)

What are the Application segmentation covered in the Contrast Agents for Magnetic Resonance Imaging (MRI) Market report?

Ans: The Applications covered in the Contrast Agents for Magnetic Resonance Imaging (MRI) Market report are Radiology, Interventional Radiology, Interventional Cardiology

What are the Type segmentation covered in the Contrast Agents for Magnetic Resonance Imaging (MRI) Market report?

Ans: The Types covered in the Contrast Agents for Magnetic Resonance Imaging (MRI) Market report are Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media

Recommended Reports

MRI Equipment

Contrast Media

MRI Accessories

1 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Overview
1.1 Product Definition
1.2 Contrast Agents for Magnetic Resonance Imaging (MRI) by Type
1.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Barium-based Contrast Media
1.2.3 Iodinated Contrast Media
1.2.4 Gadolinium-based Contrast Media
1.2.5 Microbubble Contrast Media
1.3 Contrast Agents for Magnetic Resonance Imaging (MRI) by Application
1.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value by Application (2024 VS 2031)
1.3.2 Radiology
1.3.3 Interventional Radiology
1.3.4 Interventional Cardiology
1.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Estimates and Forecasts
1.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2020-2031
1.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2020-2031
1.4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Competition by Manufacturers
2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Contrast Agents for Magnetic Resonance Imaging (MRI), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Product Type & Application
2.7 Global Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Date of Enter into This Industry
2.8 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Competitive Situation and Trends
2.8.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Contrast Agents for Magnetic Resonance Imaging (MRI) Players Market Share by Revenue
2.8.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Scenario by Region
3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2020-2031
3.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2020-2025
3.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2026-2031
3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2020-2031
3.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2020-2025
3.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2026-2031
3.4 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
3.4.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2031)
3.4.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
3.5.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2031)
3.5.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Region
3.6.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2020-2031)
3.6.3 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
3.7.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2031)
3.7.3 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Facts & Figures by Country
3.8.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2020-2031)
4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2020-2025)
4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2026-2031)
4.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2020-2031)
4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2020-2031)
4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2020-2025)
4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2026-2031)
4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2020-2031)
4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2020-2031)
5.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2020-2025)
5.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2026-2031)
5.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2020-2031)
5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2020-2031)
5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2020-2025)
5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2026-2031)
5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2020-2031)
5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare (US)
6.1.1 GE Healthcare (US) Company Information
6.1.2 GE Healthcare (US) Description and Business Overview
6.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.1.5 GE Healthcare (US) Recent Developments/Updates
6.2 Bracco Imaging (Italy)
6.2.1 Bracco Imaging (Italy) Company Information
6.2.2 Bracco Imaging (Italy) Description and Business Overview
6.2.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.2.5 Bracco Imaging (Italy) Recent Developments/Updates
6.3 Bayer HealthCare (Germany)
6.3.1 Bayer HealthCare (Germany) Company Information
6.3.2 Bayer HealthCare (Germany) Description and Business Overview
6.3.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.3.5 Bayer HealthCare (Germany) Recent Developments/Updates
6.4 Guerbet (France)
6.4.1 Guerbet (France) Company Information
6.4.2 Guerbet (France) Description and Business Overview
6.4.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.4.5 Guerbet (France) Recent Developments/Updates
6.5 Lantheus (US)
6.5.1 Lantheus (US) Company Information
6.5.2 Lantheus (US) Description and Business Overview
6.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.5.5 Lantheus (US) Recent Developments/Updates
6.6 Daiichi Sankyo (Japan)
6.6.1 Daiichi Sankyo (Japan) Company Information
6.6.2 Daiichi Sankyo (Japan) Description and Business Overview
6.6.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.6.5 Daiichi Sankyo (Japan) Recent Developments/Updates
6.7 Unijules Life Sciences (India)
6.7.1 Unijules Life Sciences (India) Company Information
6.7.2 Unijules Life Sciences (India) Description and Business Overview
6.7.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.7.5 Unijules Life Sciences (India) Recent Developments/Updates
6.8 J.B. Chemicals and Pharmaceuticals (India)
6.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
6.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
6.8.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments/Updates
6.9 Spago Nanomedicine (Sweden)
6.9.1 Spago Nanomedicine (Sweden) Company Information
6.9.2 Spago Nanomedicine (Sweden) Description and Business Overview
6.9.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.9.5 Spago Nanomedicine (Sweden) Recent Developments/Updates
6.10 Taejoon Pharm (South Korea)
6.10.1 Taejoon Pharm (South Korea) Company Information
6.10.2 Taejoon Pharm (South Korea) Description and Business Overview
6.10.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.10.5 Taejoon Pharm (South Korea) Recent Developments/Updates
6.11 Jodas (India)
6.11.1 Jodas (India) Company Information
6.11.2 Jodas (India) Description and Business Overview
6.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.11.5 Jodas (India) Recent Developments/Updates
6.12 Magnus Health (India)
6.12.1 Magnus Health (India) Company Information
6.12.2 Magnus Health (India) Description and Business Overview
6.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
6.12.5 Magnus Health (India) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Chain Analysis
7.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process Analysis
7.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Marketing
7.4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels
7.4.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
7.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Customer Analysis
8 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Dynamics
8.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
8.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Drivers
8.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Challenges
8.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
List of Tables
 Table 1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Contrast Agents for Magnetic Resonance Imaging (MRI), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Product Type & Application
 Table 12. Global Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contrast Agents for Magnetic Resonance Imaging (MRI) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2020-2025)
 Table 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2026-2031)
 Table 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2020-2025)
 Table 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2026-2031)
 Table 25. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2020-2025)
 Table 53. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2026-2031)
 Table 54. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2020-2025)
 Table 57. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2026-2031)
 Table 58. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2020-2025)
 Table 63. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2026-2031)
 Table 64. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2020-2025)
 Table 67. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2026-2031)
 Table 68. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (USD/Pcs) by Application (2026-2031)
 Table 70. GE Healthcare (US) Company Information
 Table 71. GE Healthcare (US) Description and Business Overview
 Table 72. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 74. GE Healthcare (US) Recent Developments/Updates
 Table 75. Bracco Imaging (Italy) Company Information
 Table 76. Bracco Imaging (Italy) Description and Business Overview
 Table 77. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 79. Bracco Imaging (Italy) Recent Developments/Updates
 Table 80. Bayer HealthCare (Germany) Company Information
 Table 81. Bayer HealthCare (Germany) Description and Business Overview
 Table 82. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 84. Bayer HealthCare (Germany) Recent Developments/Updates
 Table 85. Guerbet (France) Company Information
 Table 86. Guerbet (France) Description and Business Overview
 Table 87. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 89. Guerbet (France) Recent Developments/Updates
 Table 90. Lantheus (US) Company Information
 Table 91. Lantheus (US) Description and Business Overview
 Table 92. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 94. Lantheus (US) Recent Developments/Updates
 Table 95. Daiichi Sankyo (Japan) Company Information
 Table 96. Daiichi Sankyo (Japan) Description and Business Overview
 Table 97. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 99. Daiichi Sankyo (Japan) Recent Developments/Updates
 Table 100. Unijules Life Sciences (India) Company Information
 Table 101. Unijules Life Sciences (India) Description and Business Overview
 Table 102. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 104. Unijules Life Sciences (India) Recent Developments/Updates
 Table 105. J.B. Chemicals and Pharmaceuticals (India) Company Information
 Table 106. J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
 Table 107. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 109. J.B. Chemicals and Pharmaceuticals (India) Recent Developments/Updates
 Table 110. Spago Nanomedicine (Sweden) Company Information
 Table 111. Spago Nanomedicine (Sweden) Description and Business Overview
 Table 112. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 114. Spago Nanomedicine (Sweden) Recent Developments/Updates
 Table 115. Taejoon Pharm (South Korea) Company Information
 Table 116. Taejoon Pharm (South Korea) Description and Business Overview
 Table 117. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 119. Taejoon Pharm (South Korea) Recent Developments/Updates
 Table 120. Jodas (India) Company Information
 Table 121. Jodas (India) Description and Business Overview
 Table 122. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 124. Jodas (India) Recent Developments/Updates
 Table 125. Magnus Health (India) Company Information
 Table 126. Magnus Health (India) Description and Business Overview
 Table 127. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product
 Table 129. Magnus Health (India) Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List
 Table 133. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List
 Table 134. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Trends
 Table 135. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Drivers
 Table 136. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Challenges
 Table 137. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Contrast Agents for Magnetic Resonance Imaging (MRI)
 Figure 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type: 2024 & 2031
 Figure 4. Barium-based Contrast Media Product Picture
 Figure 5. Iodinated Contrast Media Product Picture
 Figure 6. Gadolinium-based Contrast Media Product Picture
 Figure 7. Microbubble Contrast Media Product Picture
 Figure 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application: 2024 & 2031
 Figure 10. Radiology
 Figure 11. Interventional Radiology
 Figure 12. Interventional Cardiology
 Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (2020-2031) & (K Pcs)
 Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Contrast Agents for Magnetic Resonance Imaging (MRI) Report Years Considered
 Figure 18. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Manufacturers in 2024
 Figure 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Contrast Agents for Magnetic Resonance Imaging (MRI) Players: Market Share by Revenue in Contrast Agents for Magnetic Resonance Imaging (MRI) in 2024
 Figure 21. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2020-2031)
 Figure 24. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2020-2031)
 Figure 36. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Contrast Agents for Magnetic Resonance Imaging (MRI) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Contrast Agents for Magnetic Resonance Imaging (MRI) by Type (2020-2031)
 Figure 58. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Contrast Agents for Magnetic Resonance Imaging (MRI) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Contrast Agents for Magnetic Resonance Imaging (MRI) by Application (2020-2031)
 Figure 61. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global MRI Contrast Agents Market Research Report 2025
Magnetic Resonance Imaging MRI Contrast Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global MRI Contrast Media Agents Market Research Report 2025
Global Gadolinium Contrast Media Market Research Report 2024
Global Gadodiamide Market Research Report 2024
Global Contrast Agents Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Magnetic Resonance Imaging Contrast Media Market Research Report 2024
Global Medical Contrast Agent Market Insights Forecast to 2030
Global Gadolinium Contrast Medium Market Research Report 2025
Iodine Formulations Contrast Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ultrasound Contrast Agents Market Research Report 2024
Global Gadolinium based Contrast Media Market Research Report 2024
Global Contrast Media Market Research Report 2025
Global Interventional X ray Contrast and Imaging Agents Market Insights Forecast to 2030
Global Contrast Media Contrast Agents Market Research Report 2024
Global High Density Contrast Media Market Research Report 2024
Global Contrast Medium Market Insights Forecast to 2030
Global Contrast Media Injector Market Insights Forecast to 2030
Global X Ray Contrast Media Market Research Report 2024
Gadolinium Contrast Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global ENT Surgery Navigation Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11O6178
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Robotics in Laparoscopic Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7R6277
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Bone Allografts Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9I8785
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions